Patents by Inventor Michael Arning

Michael Arning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating thrombocytopenia
    Patent number: 8476249
    Abstract: Invented is a method of treating thrombocytopenia in a human, in need thereof which comprises the in vivo administration of a therapeutically effective amount of a peptide or a non-peptide TPO receptor agonist and an anti-clotting agent or agents, and optional further active ingredients, to such human.
    Type: Grant
    Filed: May 6, 2010
    Date of Patent: July 2, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Connie L. Erickson-Miller, Michael Arning
  • METHOD OF TREATING THROMBOCYTOPENIA
    Publication number: 20120149749
    Abstract: Invented is a method of treating thrombocytopenia in a human in need thereof which comprises the administration of a therapeutically effective amount of a 3?-{N?-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2?-hydroxybiphenyl-3-carboxylic acid to such human.
    Type: Application
    Filed: October 14, 2009
    Publication date: June 14, 2012
    Inventors: Michael Arning, Manuel Carlos Alves-Aivado, Roya Behbahani, Yanli Deng, Connie L. Erickson-Miller, Sophia M. Goodison, Julian Jenkins, Shivakumar G. Kapsi, Bhabita Mayer, Francis Xavier Muller, Bin Peng, Teresa S. Sellers, Nicole Lee Stone, Dickens Theodore, Dennis R. Williams, Mary Beth Wire
  • METHOD OF TREATING THROMBOCYTOPENIA
    Publication number: 20120052055
    Abstract: Invented is a method of treating thrombocytopenia in a human, in need thereof which comprises the in vivo administration of a therapeutically effective amount of a peptide or a non-peptide TPO receptor agonist and an anti-clotting agent or agents, and optional further active ingredients, to such human.
    Type: Application
    Filed: May 6, 2010
    Publication date: March 1, 2012
    Applicant: Glaxosmithkline LLC
    Inventors: Connie L. Erickson-Miller, Michael Arning